Published in Medical Letter on the CDC and FDA, May 30th, 2000
The U.S. Food and Drug Administration announced on May 10 that it would permit the two leading implant makers to keep selling the products but stressed that women should be warned about risks, including the possible need for repeat surgeries. Studies by the companies, Inamed Inc.'s McGhan Medical unit and Mentor Corp , found more than 20% of women with implants required surgery to remove or replace them. Other complications included breast pain, leakage or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.